NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

體外受精 (IVF)的市場趨勢·市場佔有率·市場規模的預測 (2021-2028年):類型·設備·終端用戶·各地區

In Vitro Fertilization Market Size, Share & Trends Analysis Report By Type (Fresh Donor, Frozen Nondonor), By Instrument (Disposable Devices, Culture Media), By End-use, By Region, And Segment Forecasts, 2021 - 2028

出版商 Grand View Research, Inc. 商品編碼 1021146
出版日期 內容資訊 英文 120 Pages
商品交期: 2-10個工作天內
價格
體外受精 (IVF)的市場趨勢·市場佔有率·市場規模的預測 (2021-2028年):類型·設備·終端用戶·各地區 In Vitro Fertilization Market Size, Share & Trends Analysis Report By Type (Fresh Donor, Frozen Nondonor), By Instrument (Disposable Devices, Culture Media), By End-use, By Region, And Segment Forecasts, 2021 - 2028
出版日期: 2021年07月30日內容資訊: 英文 120 Pages
簡介

全球體外受精 (IVF)的市場規模在預測期間內預計將以6.5%的年複合成長率推移,到2028年前將成長到339億美元的規模。

進入經營者的持續努力、政府報銷制度的完善、生活方式改變導致的不孕症發病率上升等因素正在推動市場的增長。

本報告提供全球體外受精 (IVF)的市場調查,彙整市場定義和概要,市場成長的各種影響因素分析,市場規模的轉變·預測,類型·終端用戶·設備·地區/主要國家等各種區分的明細,競爭環境,市場佔有率,主要企業簡介等資訊。

第1章 調查手法·調查範圍

第2章 摘要整理

第3章 市場可變因素·趨勢·展望

  • 市場預測
  • 市場分類
  • 普及·成長預測製圖
  • 臨床試驗
  • 用戶的觀點分析
  • 市場動態
  • 商業環境分析工具

第4章 市場分析·預測:各類型

  • 新鮮非捐贈者
  • 冷凍非捐贈者
  • 新鮮捐贈者
  • 冷凍捐贈者

第5章 市場分析·預測:各終端用戶

  • 不孕治療診所
  • 醫院·其他

第6章 市場分析·預測:各設備

  • 培養液
  • 拋棄式設備
  • 設備設備

第7章 市場分析·預測:各地區·主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 競爭分析

  • 主要企業·近幾年的發展·影響分析
  • 業者情勢
  • 企業的地位
  • 企業簡介
    • OvaScience, Inc.
    • Vitrolife AB (publ)
    • EMD Serono, Inc.
    • FUJIFILM Irvine Scientific
    • The Cooper Companies, Inc.
    • Thermo Fisher Scientific, Inc.
    • Bayer AG
    • Merck & Co., Inc.
    • Cook Medical LLC (Cook Group)
    • Genea Biomedx
    • Progyny, Inc.
    • Boston IVF
    • Ferring Pharmaceutical B.V.
目錄
Product Code: 978-1-68038-823-7

In Vitro Fertilization Market Growth & Trends:

The global in vitro fertilization market size is expected to reach USD 33.9 billion by 2028, expanding at a CAGR of 6.5% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by the continuous efforts of the market players, government initiatives for better reimbursement policies, and an increase in the incidence of infertility due to lifestyle changes. Expansion of fertility procedures, such as ICSI for treating infertility, is expected to positively impact the market growth in the near future.

Moreover, the availability of genomic testing facilities that enable the prevention of the transfer of genetic disorders during in vitro fertilization (IVF) is further expected to drive the market. The insurance companies are providing coverage to IVF procedures owing to an increase in the number of IVF treatments. This has led to competitive pricing and has moderated the IVF treatment costs as the procedure has been a successfully practiced technology, driving the market with more treatment automation and standardization.

A decline in the Total Fertility Rate (TFR) is a result of factors, such as a behavioral shift in society, a shift from rural to urban societies, increased age of first-time mothers or the age at which women give birth to their first child, an increasing number of women in the labor force, postponement of marriage, and lower marriage rates.

The in-person fertility treatments in the U.S. and Canada were suspended in March 2020 by the Canadian Fertility and Andrology Society and the American Society of Reproductive Medicine due to the COVID-19 pandemic. However, treatments are resuming in many countries with the ease of restrictions, including the developing nations. For instance, in July 2020, Medicover Fertility, an IVF center in India, announced to resume the IVF procedures after the initial COVID-19 risk assessment.

In Vitro Fertilization Market Report Highlights:

  • Culture media dominated the IVF market in 2020 accounting for the maximum revenue share. Several research activities are being undertaken to improve the efficiency of culture media
  • For instance, Vitrolife showcased its research on SpermFreeze solution at the American Society for Reproductive Medicine (ASRM) that established the effectiveness of its solution for sperm recovery & sperm-hyaluronic acid-binding
  • Europe dominated the global market with the highest revenue share in 2020 due to the availability of affordable treatments, adherence to medical standards, and quick adoption of advanced technologies, such as time-lapse microscopy by the clinics in the region
  • The APAC region is expected to witness an increased demand for IVF owing to fertility tourism and the availability of funding for the treatment. In Japan, eligible couples can apply for co-funding for a maximum of three cycles with USD 1,920 for each cycle
  • The developing countries in the APAC region are undertaking legal reforms to promote treatment adoption in the region. For instance, in February 2020, the Government of India approved a bill for the regulation of clinics offering reproduction assistance services, including IVF, artificial insemination, and surrogacy
  • In January 2020, Merck received Marketing Authorization (MA) from the European Commission (EC) for its recombinant human follicle-stimulating hormone, GONAL-f (follitropin alfa) 150 IU pen

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Type
    • 1.1.2 End - Use
    • 1.1.3 Instrument
    • 1.1.4 Regional Scope
    • 1.1.5 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
    • 1.6.2 Volume Price Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Type
    • 2.2.2 End Use
    • 2.2.3 Instrument
    • 2.2.4 Region
  • 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Market Segmentation
  • 3.3 Penetration & Growth Prospect Mapping
    • 3.3.1 Analysis
  • 3.4 Clinical Trials
  • 3.5 User Perspective Analysis
    • 3.5.1 Consumer Behavior Analysis
    • 3.5.2 Market Influencer Analysis
  • 3.6 Market Dynamics
    • 3.6.1 Market Driver Analysis
      • 3.6.1.1 Rising reprotourism
      • 3.6.1.2 Technological advancements in IVF
      • 3.6.1.3 Favorable government funding
      • 3.6.1.4 Late initiation of family
      • 3.6.1.5 Increasing incidence rate of male and female infertility
      • 3.6.1.6 Mergers and acquisitions (M&A)
    • 3.6.2 Market Restraint Analysis
      • 3.6.2.1 High cost of IVF treatment
      • 3.6.2.2 Lack of regulatory framework and uniform regulations
      • 3.6.2.3 Vulnerability of women depending on cross - border reprotourism market
  • 3.7 Business Environment Analysis Tools
    • 3.7.1 Porter's five forces analysis
      • 3.7.1.1 Bargaining power of buyers: Low
      • 3.7.1.2 Bargaining power of suppliers: Moderate
      • 3.7.1.3 Competitive rivalry: High
      • 3.7.1.4 Threat of new entrants: Moderate
      • 3.7.1.5 Threat of substitutes: Low
    • 3.7.2 SWOT Analysis, by PESTEL
      • 3.7.2.1 Political & legal
      • 3.7.2.2 Economic
      • 3.7.2.3 Technological
    • 3.7.3 Major Deals & Strategic Alliances Analysis
      • 3.7.3.1 Joint ventures
      • 3.7.3.2 Mergers & acquisitions
    • 3.7.4 Qualitative Analysis: Impact of COVID - 19 on IVF Market

Chapter 4 In Vitro Fertilization Market: Type Analysis

  • 4.1 In Vitro Fertilization by Type Market Share Analysis, 2020 & 2028
  • 4.2 Segment Dashboard
  • 4.3 Global In Vitro Fertilization Procedures Market, by Type, 2016 - 2028
  • 4.4 Market Size and Forecasts and Trend Analysis, 2016 - 2028 for the Type
    • 4.4.1 Fresh Nondonor
      • 4.4.1.1 Fresh non-donor market, 2016 - 2028 (USD Million)
    • 4.4.2 Frozen Nondonor
      • 4.4.2.1 Frozen non-donor market, 2016 - 2028 (USD Million)
    • 4.4.3 Fresh Donor
      • 4.4.3.1 Fresh donor market, 2016 - 2028 (USD Million)
    • 4.4.4 Frozen Donor
      • 4.4.4.1 Frozen donor market, 2016 - 2028 (USD Million)

Chapter 5 In Vitro Fertilization Market: End-use Analysis

  • 5.1 In Vitro Fertilization End-use Market Share Analysis, 2020 and 2028
  • 5.2 Segment Dashboard
  • 5.3 Market Size and Forecasts and Trend Analysis, 2016 - 2028 for the Following End-Use
    • 5.3.1 Fertility Clinics
      • 5.3.1.1 Fertility clinics market, 2016 - 2028 (USD Million)
    • 5.3.2 Hospitals and Other Settings
      • 5.3.2.1 Hospitals and other settings market, 2016 - 2028 (USD Million)

Chapter 6 In Vitro Fertilization Market: Instrument Analysis

  • 6.1 In Vitro Fertilization (IVF) Market Share Analysis, 2020 & 2028
  • 6.2 Segment Dashboard
  • 6.3 Global IVF Market, by Instrument, 2020 to 2028
  • 6.4 Market Size & Forecasts and Trend Analysis, 2016 to 2028 for the Instrument:
    • 6.4.1 Culture Media
      • 6.4.1.1 Culture media market, 2016 - 2028 (USD Million)
    • 6.4.2 Disposable Devices
      • 6.4.2.1 Disposable devices market, 2016 - 2028 (USD Million)
    • 6.4.3 Capital Equipment
      • 6.4.3.1 Capital equipment market, 2016 - 2028 (USD Million)

Chapter 7 Regional Outlook

  • 7.1 Regional market share analysis, 2020 & 2028
  • 7.2 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 7.3 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
    • 7.3.1 North America
    • 7.3.2 Europe
    • 7.3.3 Asia Pacific
    • 7.3.4 Latin America
    • 7.3.5 MEA
  • 7.4 List of Few Fertility Clinics
    • 7.4.1 North America
    • 7.4.2 Europe
    • 7.4.3 Asia Pacific
    • 7.4.4 Latin America
    • 7.4.5 MEA
  • 7.5 Market Size, & Forecasts and Trend Analysis, 2020 to 2028
    • 7.5.1 North America
      • 7.5.1.1 North America IVF market, 2016 - 2028 (USD Million)
      • 7.5.1.2 The U.S.
      • 7.5.1.2.1 Impact of COVID - 19 pandemic
      • 7.5.1.2.2 Regulatory & reimbursement scenario
      • 7.5.1.2.3 U.S. IVF market, 2016 - 2028 (USD Million)
      • 7.5.1.3 Canada
      • 7.5.1.3.1 Impact of COVID - 19 pandemic
      • 7.5.1.3.2 Regulatory & reimbursement scenario
      • 7.5.1.3.3 Canada IVF market, 2016 - 2028 (USD Million)
    • 7.5.2 Europe
      • 7.5.2.1 Europe IVF market, 2016 - 2028 (USD Million)
      • 7.5.2.2 France
      • 7.5.2.2.1 Impact of COVID - 19 pandemic
      • 7.5.2.2.2 Regulatory & reimbursement scenario
      • 7.5.2.2.3 France IVF market, 2016 - 2028 (USD Million)
      • 7.5.2.3 Germany
      • 7.5.2.3.1 Impact of COVID - 19 pandemic
      • 7.5.2.3.2 Regulatory & reimbursement scenario
      • 7.5.2.3.3 Germany IVF market, 2016 - 2028 (USD Million)
      • 7.5.2.4 Italy
      • 7.5.2.4.1 Impact of COVID - 19 pandemic
      • 7.5.2.4.2 Regulatory & reimbursement scenario
      • 7.5.2.4.3 Italy IVF market, 2016 - 2028 (USD Million)
      • 7.5.2.5 Spain
      • 7.5.2.5.1 Impact of COVID - 19 pandemic
      • 7.5.2.5.2 Regulatory & reimbursement scenario
      • 7.5.2.5.3 Spain IVF market, 2016 - 2028 (USD Million)
      • 7.5.2.6 The U.K.
      • 7.5.2.6.1 Impact of COVID - 19 pandemic
      • 7.5.2.6.2 Regulatory & reimbursement scenario
      • 7.5.2.6.3 UK IVF market, 2016 - 2028 (USD Million)
      • 7.5.2.7 Belgium
      • 7.5.2.7.1 Impact of COVID - 19 pandemic
      • 7.5.2.7.2 Regulatory & reimbursement scenario
      • 7.5.2.7.3 Belgium IVF market, 2016 - 2028 (USD Million)
      • 7.5.2.8 The Netherlands
      • 7.5.2.8.1 Impact of COVID - 19 pandemic
      • 7.5.2.8.2 Regulatory & reimbursement scenario
      • 7.5.2.8.3 Netherlands IVF market, 2016 - 2028 (USD Million)
      • 7.5.2.9 Switzerland
      • 7.5.2.9.1 Impact of COVID - 19 pandemic
      • 7.5.2.9.2 Regulatory & reimbursement scenario
      • 7.5.2.9.3 Switzerland IVF market, 2016 - 2028 (USD Million)
    • 7.5.3 Asia Pacific
      • 7.5.3.1 Asia Pacific IVF market, 2016 - 2028 (USD Million)
      • 7.5.3.2 Japan
      • 7.5.3.2.1 Impact of COVID - 19 pandemic
      • 7.5.3.2.2 Regulatory & reimbursement scenario
      • 7.5.3.2.3 Japan IVF market, 2016 - 2028 (USD Million)
      • 7.5.3.3 China
      • 7.5.3.3.1 Impact of COVID - 19 pandemic
      • 7.5.3.3.2 Regulatory & reimbursement scenario
      • 7.5.3.3.3 China IVF market, 2016 - 2028 (USD Million)
      • 7.5.3.4 India
      • 7.5.3.4.1 Impact of COVID - 19 pandemic
      • 7.5.3.4.2 Regulatory & reimbursement scenario
      • 7.5.3.4.3 India IVF market, 2016 - 2028 (USD Million)
    • 7.5.4 Latin America
      • 7.5.4.1 Latin America IVF market, 2016 - 2028 (USD Million)
      • 7.5.4.2 Brazil
      • 7.5.4.2.1 Impact of COVID - 19 pandemic
      • 7.5.4.2.2 Regulatory & reimbursement scenario
      • 7.5.4.2.3 Brazil IVF market, 2016 - 2028 (USD Million)
      • 7.5.4.3 Mexico
      • 7.5.4.3.1 Impact of COVID - 19 pandemic
      • 7.5.4.3.2 Regulatory & reimbursement scenario
      • 7.5.4.3.3 Mexico IVF market, 2016 - 2028 (USD Million)
    • 7.5.5 Middle East & Africa
      • 7.5.5.1 MEA IVF market, 2016 - 2028 (USD Million)
      • 7.5.5.2 South Africa
      • 7.5.5.2.1 Impact of COVID - 19 pandemic
      • 7.5.5.2.2 Regulatory & reimbursement scenario
      • 7.5.5.2.3 South Africa IVF market, 2016 - 2028 (USD Million)

Chapter 8 Competitive Analysis

  • 8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
  • 8.2 Vendor Landscape
    • 8.2.1 Strategy Mapping
    • 8.2.2 Launch of New Products
    • 8.2.3 Merger and Acquisition
    • 8.2.4 Product Approvals
    • 8.2.5 Partnerships
    • 8.2.6 Marketing & Promotions
  • 8.3 Company Market Position Analysis
  • 8.4 Company Profiles
    • 8.4.1 OvaScience, Inc.
      • 8.4.1.1 Company overview
      • 8.4.1.2 Financial performance
      • 8.4.1.3 Product benchmarking
      • 8.4.1.4 Strategic initiatives
      • 8.4.1.5 SWOT analysis
    • 8.4.2 Vitrolife AB (publ)
      • 8.4.2.1 Company overview
      • 8.4.2.2 Financial performance
      • 8.4.2.3 Product benchmarking
      • 8.4.2.4 Strategic initiatives
      • 8.4.2.5 SWOT analysis
    • 8.4.3 EMD Serono, Inc.
      • 8.4.3.1 Company overview
      • 8.4.3.2 Financial performance
      • 8.4.3.3 Product benchmarking
      • 8.4.3.4 Strategic initiatives
      • 8.4.3.5 SWOT analysis
    • 8.4.4 FUJIFILM Irvine Scientific
      • 8.4.4.1 Company overview
      • 8.4.4.2 Financial performance
      • 8.4.4.3 Product benchmarking
      • 8.4.4.4 Strategic initiatives
      • 8.4.4.5 SWOT analysis
    • 8.4.5 The Cooper Companies, Inc.
      • 8.4.5.1 Company overview
      • 8.4.5.2 Financial performance
      • 8.4.5.3 Product benchmarking
      • 8.4.5.4 Strategic initiatives
      • 8.4.5.5 SWOT analysis
    • 8.4.6 Thermo Fisher Scientific, Inc.
      • 8.4.6.1 Company overview
      • 8.4.6.2 Financial performance
      • 8.4.6.3 Product benchmarking
      • 8.4.6.4 Strategic initiatives
      • 8.4.6.5 SWOT analysis
    • 8.4.7 Bayer AG
      • 8.4.7.1 Company overview
      • 8.4.7.2 Financial performance
      • 8.4.7.3 Product benchmarking
      • 8.4.7.4 Strategic initiatives
      • 8.4.7.5 SWOT analysis
    • 8.4.8 Merck & Co., Inc.
      • 8.4.8.1 Company overview
      • 8.4.8.2 Financial performance
      • 8.4.8.3 Product benchmarking
      • 8.4.8.4 Strategic initiatives
      • 8.4.8.5 SWOT analysis
    • 8.4.9 Cook Medical LLC (Cook Group)
      • 8.4.9.1 Company overview
      • 8.4.9.2 Financial performance
      • 8.4.9.3 Product benchmarking
      • 8.4.9.4 Strategic initiatives
    • 8.4.10 Genea Biomedx
      • 8.4.10.1 Company overview
      • 8.4.10.2 Financial performance
      • 8.4.10.3 Product benchmarking
      • 8.4.10.4 Strategic initiatives
    • 8.4.11 Progyny, Inc.
      • 8.4.11.1 Company overview
      • 8.4.11.2 Financial performance
      • 8.4.11.3 Services benchmarking
      • 8.4.11.4 Strategic initiatives
    • 8.4.12 Boston IVF
      • 8.4.12.1 Company overview
      • 8.4.12.2 Financial performance
      • 8.4.12.3 Product benchmarking
      • 8.4.12.4 Strategic initiatives
    • 8.4.13 Ferring Pharmaceutical B.V.
      • 8.4.13.1 Company overview
      • 8.4.13.2 Financial performance
      • 8.4.13.3 Product benchmarking
      • 8.4.13.4 Strategic initiatives

List of Tables

  • 1. List of secondary sources
  • 2. List of abbreviation
  • 3. Clinical trial analysis
  • 4. Comparison between the fresh and frozen donor treatment (U.S.)
  • 5. Canadian law on ART
  • 6. Status of public funding for IVF in Canada
  • 7. Global disposable devices market estimates and forecast, 2016 - 2028 (USD Billion)
  • 8. Global culture media market estimates and forecast, 2016 - 2028 (USD Billion)
  • 9. Global fresh donor market estimates and forecast, 2016 - 2028 (USD Billion)
  • 10. Global frozen donor market estimates and forecast, 2016 - 2028 (USD Billion)
  • 11. Global fresh non-donor equipment market estimates and forecast, 2016 - 2028 (USD Billion)
  • 12. Global frozen non-donor market estimates and forecast, 2016 - 2028 (USD Billion)
  • 13. Global fertility clinics market estimates and forecast, 2016 - 2028 (USD Billion)
  • 14. Global hospitals & others setting market estimates and forecast, 2016 - 2028 (USD Billion)
  • 15. North America in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 16. North America in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 17. North America in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 18. North America in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 19. The U.S. in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 20. The U.S. in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 21. The U.S. in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 22. The U.S. in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 23. Europe in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 24. Europe in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 25. Europe in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 26. Europe in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 27. France in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 28. France in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 29. France in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 30. France in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 31. Germany in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 32. Germany in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 33. Germany in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 34. Germany in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 35. Italy in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 36. Italy in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 37. Italy in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 38. Italy in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 39. Spain in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 40. Spain in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 41. Spain in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 42. Spain in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 43. The U.K. in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 44. The U.K. in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 45. The U.K. in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 46. The U.K. in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 47. Belgium in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 48. Belgium in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 49. Belgium in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 50. Belgium in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 51. The Netherlands in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 52. The Netherlands in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 53. The Netherlands in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 54. The Netherlands in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 55. Switzerland in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 56. Switzerland in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 57. Switzerland in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 58. Switzerland in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 59. Asia Pacific in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 60. Asia Pacific in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 61. Asia Pacific in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 62. Asia Pacific in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 63. Japan in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 64. Japan in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 65. Japan in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 66. Japan in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 67. China in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 68. China in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 69. China in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 70. China in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 71. India in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 72. India in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 73. India in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 74. India in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 75. Latin America in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 76. Latin America in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 77. Latin America in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 78. Latin America in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 79. Brazil in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 80. Brazil in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 81. Brazil in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 82. Brazil in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 83. Mexico in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 84. Mexico in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 85. Mexico in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 86. Mexico in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 87. Middle East & Africa in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 88. Middle East & Africa in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 89. Middle East & Africa in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 90. Middle East & Africa in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)
  • 91. South Africa in vitro fertilization market estimates and forecast, 2016 - 2028 (USD Billion)
  • 92. South Africa in vitro fertilization market revenue estimates and forecast by instrument, 2016 - 2028 (USD Billion)
  • 93. South Africa in vitro fertilization market revenue estimates and forecast by procedure type, 2016 - 2028 (USD Billion)
  • 94. South Africa in vitro fertilization market revenue estimates and forecast by end use, 2016 - 2028 (USD Billion)

List of Figures

  • 1. Market research process
  • 2. Data triangulation techniques
  • 3. Primary research pattern
  • 4. Market research approaches
  • 5. Supply-chain-based sizing & forecasting
  • 6. QFD modeling for market share assessment
  • 7. Market formulation & validation
  • 8. In Vitro Fertilization (IVF) market summary, 2020 (USD Million)
  • 9. In Vitro Fertilization (IVF) market segmentation
  • 10. Penetration & growth prospect mapping
  • 11. Market trends & outlook
  • 12. Market driver relevance analysis (Current & future impact)
  • 13. Semen sample imported in Brazil (Units)
  • 14. Female age-based chance of conception
  • 15. Market restraint relevance analysis (Current & future impact)
  • 16. IVF market: Type movement analysis
  • 17. IVF market type outlook: Key takeaways
  • 18. Global IVF procedures market, by type, 2016 - 2028 (USD Million)
  • 19. Fresh nondonor market, 2016 - 2028 (USD Million)
  • 20. Frozen nondonor market 2016 - 2028 (USD Million)
  • 21. Fresh donor market 2016 - 2028 (USD Million)
  • 22. Frozen donor market 2016 - 2028 (USD Million)
  • 23. IVF market: End-use movement analysis
  • 24. IVF market end-use outlook: Key takeaways
  • 25. Fertility clinics market, 2016 - 2028 (USD Million)
  • 26. Hospitals and other settings market, 2016 - 2028 (USD Million)
  • 27. In Vitro Fertilization (IVF) market: Instrument movement analysis
  • 28. IVF market Instrument outlook: Key takeaways
  • 29. IVF instrument market, 2016 - 2028 (USD Million)
  • 30. Culture media market, 2016 - 2028 (USD Million)
  • 31. Disposable devices market, 2016 - 2028 (USD Million)
  • 32. Capital equipment market, 2016 - 2028 (USD Million)
  • 33. Regional outlook, 2020 & 2028
  • 34. Regional market place: Key takeaways
  • 35. North America IVF market, 2016 - 2028 (USD Million)
  • 36. North America IVF instrument market, 2016 - 2028 (USD Million)
  • 37. The U.S. IVF market, 2016 - 2028 (USD Million)
  • 38. The U.S. IVF instrument market, 2016 - 2028 (USD Million)
  • 39. Canada IVF market, 2016 - 2028 (USD Million)
  • 40. Canada IVF instrument market, 2016 - 2028 (USD Million)
  • 41. Europe IVF market, 2016 - 2028 (USD Million)
  • 42. Europe IVF instrument market, 2016 - 2028 (USD Million)
  • 43. France IVF market, 2016 - 2028 (USD Million)
  • 44. France IVF instrument market, 2016 - 2028 (USD Million)
  • 45. Germany IVF market, 2016 - 2028 (USD Million)
  • 46. Germany IVF instrument market, 2016 - 2028 (USD Million)
  • 47. Italy IVF market, 2016 - 2028 (USD Million)
  • 48. Italy IVF instrument market, 2016 - 2028 (USD Million)
  • 49. Spain IVF market, 2016 - 2028 (USD Million)
  • 50. Spain IVF instrument market, 2016 - 2028 (USD Million)
  • 51. The U.K. IVF market, 2016 - 2028 (USD Million)
  • 52. The U.K. IVF instrument market, 2016 - 2028 (USD Million)
  • 53. Belgium IVF market, 2016 - 2028 (USD Million)
  • 54. Belgium IVF instrument market, 2016 - 2028 (USD Million)
  • 55. The Netherlands IVF market, 2016 - 2028 (USD Million)
  • 56. The Netherlands IVF instrument market, 2016 - 2028 (USD Million)
  • 57. Switzerland IVF market, 2016 - 2028 (USD Million)
  • 58. Switzerland IVF instrument market, 2016 - 2028 (USD Million)
  • 59. Asia Pacific IVF market, 2016 - 2028 (USD Million)
  • 60. Asia Pacific IVF instrument market, 2016 - 2028 (USD Million)
  • 61. Japan IVF market, 2016 - 2028 (USD Million)
  • 62. Japan IVF instrument market, 2016 - 2028 (USD Million)
  • 63. China IVF market, 2016 - 2028 (USD Million)
  • 64. China IVF instrument market, 2016 - 2028 (USD Million)
  • 65. India IVF market, 2016 - 2028 (USD Million)
  • 66. India IVF instrument market, 2016 - 2028 (USD Million)
  • 67. Latin America IVF market, 2016 - 2028 (USD million)
  • 68. Latin America IVF instrument market, 2016 - 2028 (USD million)
  • 69. Brazil IVF market, 2016 - 2028 (USD million)
  • 70. Brazil IVF instrument market, 2016 - 2028 (USD million)
  • 71. Mexico IVF market, 2016 - 2028 (USD million)
  • 72. Mexico IVF instrument market, 2016 - 2028 (USD million)
  • 73. MEA IVF market, 2016 - 2028 (USD Million)
  • 74. MEA IVF instrument market, 2016 - 2028 (USD Million)
  • 75. South Africa IVF market, 2016 - 2028 (USD million)
  • 76. South Africa IVF instrument market, 2016 - 2028 (USD million)
  • 77. Strategy framework
  • 78. Strategy mapping
  • 79. Company market position analysis